New antibiotics on the way: How pharma can tackle the Antimicrobial Resistance crisis
The overuse and misuse of antimicrobials in humans and animals have escalated…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
The Next Frontier: Pharma and Longevity
From The Epic of Gilgamesh, the earliest surviving book, to the controversial…
mRNA personalized Cancer Vaccines: BioNTech and Moderna Race to the Finish Line
With the emergence of immunotherapy for oncology, cancer vaccines are cropping…
Cell and Gene Therapy Clinical Trials – 2024 Edition
Gene therapy clinical trials promise transformative breakthroughs in treating…
From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
Navigating the Immunoglobulin Therapy Landscape: An Overview
The Immunoglobulin Replacement Therapy (IG) market is growing, as these…
Can "Digital Vaccines" be a game-changer in lifestyle diseases?
Digital vaccines are clinically proven "no injection, no ingestion" vaccines.…
RSV vaccines: A powerful tool to protect against RSV
According tο a recent systematic analysis focusing on children younger than…
Declining confidence in childhood vaccines: A threat for today's kids.
"We cannot allow confidence in routine immunizations to become another victim…
AI in Healthcare: Navigating the Global Landscape and Strategic Insights for Pharma and Biotech Companies
Artificial Intelligence (AI) has emerged as a transformative force in the…
